PreveCeutical Granted Approval to Acquire and Use Human Mucosal Tissue for Final Phase of Sol-Gel Program

Stock Information for PreveCeutical Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About PreveCeutical Medical Inc.

PreveCeutical Grants Asterion Option to Purchase up to a 51% Interest in Sol-Gel Intellectual Property
PreveCeutical Named in Lawsuit
PreveCeutical Successfully Incorporates Medicinal Cannabis Extracts into the Sol-Gel Drug Delivery System
PreveCeutical Announces Appointment of New Directors
PreveCeutical Announces Further Positive Results from its Dual Gene Therapy Research Program
PreveCeutical Secures $300,000 Loan and Resignation of a Director
PreveCeutical Partnership Leads to Two New Patent Filings
PreveCeutical Files Application to Human Ethics Committee to Acquire Human Tissue for the Final Phase of the Sol-Gel Program

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.